Blumenthal named VP of Global Oncology Regulatory Affairs at Merck

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Gideon Blumenthal was named vice president for Global Oncology Regulatory Affairs at Merck.

He is a former deputy director of the FDA Oncology Center of Excellence.

Table of Contents

YOU MAY BE INTERESTED IN

The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login